16.65
-2.41 (-12.64%)
| Penutupan Terdahulu | 19.06 |
| Buka | 18.20 |
| Jumlah Dagangan | 31,587 |
| Purata Dagangan (3B) | 26,816 |
| Modal Pasaran | 179,263,824 |
| Harga / Jualan (P/S) | 2.30 |
| Harga / Buku (P/B) | 2.30 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Jun 2025 - 6 Jun 2025 |
| Margin Keuntungan | -45.59% |
| Margin Operasi (TTM) | -11.41% |
| EPS Cair (TTM) | -3.22 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.40% |
| Nisbah Semasa (MRQ) | 3.02 |
| Aliran Tunai Operasi (OCF TTM) | -75.58 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.97 M |
| Pulangan Atas Aset (ROA TTM) | -14.39% |
| Pulangan Atas Ekuiti (ROE TTM) | -37.03% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Burning Rock Biotech Limited | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -3.5 |
| Purata | -0.67 |
|
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| % Dimiliki oleh Orang Dalam | 3.92% |
| % Dimiliki oleh Institusi | 59.86% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Redwood Wealth Management Group, Llc | 31 Mar 2026 | 18,278 |
| Shen Neil Nanpeng | 31 Dec 2025 | 885 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |